Document is current

Any future updates will be listed below

Drawbacks of immune checkpoint inhibition and rigorous management for immune-related adverse events along with a mathematical model to assess therapy success and optimum therapy duration and a strategy against tumor plasticity

Crossref DOI link: https://doi.org/10.1007/s00432-023-04718-x

Published Online: 2023-04-19

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark